LONG MINI-FUTURE - PFIZER INC | Real-time Bid/Ask 08:59:39 17/05/2024 BST | ||
| 1.22 CHF / 1.24 CHF | +2.50% |
|
| Current month | +34.83% | ||
| 1 month | +30.43% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
PFIZER, INC.
Latest news about PFIZER, INC.
| Date | Price | Change |
|---|---|---|
| 16/05/24 | 1.2 | +0.84% |
| 15/05/24 | 1.19 | +1.71% |
| 14/05/24 | 1.17 | -0.85% |
| 13/05/24 | 1.18 | +4.42% |
| 10/05/24 | 1.13 | +0.89% |
Delayed Quote Swiss Exchange
Last update May 16, 2024 at 04:20 pm
More quotesStatic data
| Product type | Knock-Out mit Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | PFIZER, INC. |
| Issuer | 
Vontobel
|
| MPFEB | |
| ISIN | CH0147459603 |
| Date issued | 23/01/2012 |
| Strike | 16.27 $ |
| Maturity | Unlimited |
| Parity | 9.48 : 1 |
| Emission price | 0.33 CHF |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | CHF |
Technical Indicators
| Highest since issue | 4.37 CHF |
|---|---|
| Lowest since issue | - CHF |
| Spread | 0.02 CHF |
| Spread % | 1.61% |
Company Profile
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
Consensus: Pfizer, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.92
USD
Average target price
31.94
USD
Spread / Average Target
+10.44%
- Stock Market
- Certificates
- MPFEB Certificat
